Swedish Orphan Biovitrum
Nathalie Camargo is an experienced professional in pharmaceutical formulation and process management, currently serving as a Senior Process Manager at Sobi since July 2023. Previously, Nathalie held the position of CMC & Formulation Development Lead at Cellestia Biotech, focusing on preclinical formulation design and the development of new dosage forms for early clinical phases. Nathalie's career includes roles such as Formulation Development and Regulatory Affairs Manager at Lesaffre Human Care, Product Transfer Manager at ROTTENDORF PHARMA France, and Senior Formulation Scientist at Ipsen, among others. Nathalie's expertise encompasses drug substance and product manufacturing, project management, and collaboration with various external parties. Nathalie holds a Doctorate in Formulation - Pharmaceutical Technology and a PharmD from Paris-Sud University.
This person is not in any teams
This person is not in any offices
Swedish Orphan Biovitrum
9 followers
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases.